GH Share Price

GH Share Price

NASDAQ: GHRS | Healthcare
$17.54
-$1.02 (-5.47%) Last updated on 21 Nov, 2026 | 02:29 IST
  • Performance
  • Chart
  • Fundamentals
  • Profit & Loss
  • Balance Sheet
  • Cash Flow
  • About
  • Price history
  • FAQs

GH Stock Performance

Open
$18.01
Prev. Close
$18.55
Circuit Range
N/A
Day Range
$17.33 - $18.01
Year Range
$12.10 - $31.16
Volume
26,850
Average Traded
$17.62

GH Share Price Today

As of 22 November 2026, GH Research PLC's share price is $17.54. The stock opened at $18.01, compared to its previous close of $18.55. During today's trading session, GH Research PLC's share price traded between $17.33 and $18.01, with an average price of $17.67. Over the past 52 weeks, the stock has recorded a high of $31.16 and a low of $12.10. In terms of performance, GH Research PLC's share price has declined by 26.91% over the last six months and is up 15.21% on a year-on-year basis.

GH Share Price Chart

Line chart of the GH price trend over the selected period. The price fell overall, ranging from 17.33 to 18.14, ending at 17.54.
$17.33$18.01
L
Show Current Price
H

GH Stock Fundamentals & Key Indicators

Market Cap
N/A
PE Ratio (TTM)
N/A
Dividend Yield
N/A
EPS (TTM)
N/A
Revenue (TTM)
$0.00
Return On Equity (TTM)
N/A
Profit Margin
N/A
Debt to Equity
N/A
Quarterly Earnings Growth YoY
N/A

GH Annual Profit & Loss

All figures in USD

Particulars2022202320242025
Revenue$0.00$0.00$0.00$0.00
Net Profit-$22.46-$35.59-$38.96-$48.26
Net Profit MarginN/AN/AN/AN/A
Income ChangeN/A-58.46%-9.47%-23.87%

GH Balance Sheet

All figures in USD Million

Particulars2025202420232022
Non Current Assets2.2534.0562.2185.82
Current Assets285.98154.23164.09168.54
Total Assets288.23188.27226.3254.36
Non Current Liabilities0.150.370.630.0
Current Liabilities8.388.956.74.55
Total Liabilities8.539.327.334.55
Shareholders' Equity279.7178.95218.97249.82

GH Cash Flow

Annually

All figures in USD Million

Particulars2025202420232022
Operating-43.55-42.29-33.34-26.2
Investing46.1765.14-54.1-84.69
Financing139.65-0.3-0.20.0

About GH

GH Research PLC is a clinical-stage biopharmaceutical company dedicated to transforming the lives of patients by developing a practice-changing treatment for depression. Its initial focus is on developing novel and proprietary mebufotenin therapies for the treatment of patients with Treatment-Resistant Depression, or TRD. Its portfolio currently includes GH001, a proprietary inhalable mebufotenin product candidate, and GH002, a proprietary intravenous mebufotenin product candidate. The group has only a single segment: Research and Development.

GH Historical Returns

Share price history by day, with open and close prices and the day's change
MonthOpenCloseChange %
Nov 2026
$21.27
$17.59
-15.96%
Oct 2026
$23.24
$20.93
-10.94%
Sep 2026
$27.30
$23.50
-17.95%
Aug 2026
$27.55
$28.64
+1.99%
Jul 2026
$26.94
$28.08
+4.00%
Jun 2026
$24.05
$27.00
+12.55%
May 2026
$20.29
$23.99
+17.08%
Apr 2026
$14.62
$20.49
+45.42%
Mar 2026
$14.57
$14.09
-5.18%
Feb 2026
$16.01
$14.86
-5.41%
Jan 2026
$12.83
$15.71
+23.80%
Dec 2025
$14.91
$12.69
-16.62%

GH Share Price FAQs